Skip to main content
Elsevier
Shopping Cart
openUserAccount

Books in Life sciences

BooksJournals
61-70 of 20378 results in All results

Insomnia Disorder

  • 1st Edition
  • November 1, 2029
  • Jaime M. Monti + 1 more
  • English
The field of sleep pharmacology is dynamic in nature and rapid advances are occurring in the field. For example, screening for new drug candidates, development of new drugs, identification of molecular targets, and works related to its efficacy and safety profiles. Furthermore, this leads to the development of evidence-based therapeutic guidelines. Insomnia Disorder: Epidemiology, Causes, and Pharmacotherapy consolidates the latest developments into one volume. It provides the latest, up-to-date knowledge regarding sleep and sleep therapeutics for sleep physicians, sleep researchers, psychiatrists, and any medical professional interested in the interdisciplinary areas of sleep therapeutics. Chapters include topics such as neurobiology, neurotransmitters, regulation of sleep and wakefulness, and overview of all current pharmacotherapies for insomnia.

Perspectives on Bioequivalence Pathways for Drug Product Approval

  • 1st Edition
  • November 1, 2029
  • Vaibhav Dubey + 1 more
  • English
Perspectives on Bioequivalence Pathways for Drug Product Approval: Across Dosage Form, Route of Administration and Geographical Jurisdictions explains the role of alternative approaches to bioequivalence across various dosage forms, route of administration, and regulatory bodies with an ultimate aim of reducing clinical trial and bioequivalence study burdens. Sections focus on alternative bioequivalence approaches that can be fostered to minimize human testing, along with instigating new ideas and opening new avenues for the development of such approaches. It will be useful to pharmaceutical scientists working to produce affordable medicines to all as well as regulatory agencies, pharmaceutical companies, formulation scientists and clinical scientists.This book covers several administration routes and deals with biowaivers for dosage form, routes of administration and geographical jurisdiction. Divided into five sections, including oral drug products, ophthalmic drug products, topical and transdermal drug products, orally inhaled and nasal drug products, and complex injectables, this book includes multiple real-world case studies alongside theory and protocols.

Building the Future of the Supply Chain

  • 1st Edition
  • November 1, 2029
  • Darin Detwiler + 1 more
  • English
Building the Future of Supply Chains: Food and Pharmaceutical addresses the multiple, dynamic dimensions of concerns that play a role in shaping and interpreting the future of supply chains across not only the food industry, but other industries integral to the global population. This is a broad reference featuring a range of global corporate, academic and industry perspectives that contribute to the overall issues of supply chains. It’s divided into sections that focus on a range of concerns, from scientific and technical to workforce and ethics. This is a practical reference useful for anyone who is part of the supply chain involving management, safety, quality, legal, and ethical.

Pearls in Clinical Epidemiology and Trial Methods in Rheumatic and Musculoskeletal Diseases

  • 1st Edition
  • November 1, 2029
  • Hyon K. Choi + 1 more
  • English
Pearls in Clinical Epidemiology and Trial Methods in Rheumatic and Musculoskeletal Diseases is an essential reference of modern clinical epidemiology and trials, specifically in rheumatic diseases and MSK conditions with unique methodologic features, using relevant examples. This book can be used as learning tool for clinical training programs and practitioners to help resolve the widening gap between the sophisticated research methods in the field and readers’ understanding of the resulting knowledge to enhance readers’ critical appraisal skills for evidence-based medicine.Written by leaders in the field who have conducted landmark studies for clinical and public health impact as well as FDA and EMA new drug approvals. In doing so, they have developed unique knowhows and pearls specific to these conditions, which will be great learning material for current and budding researchers, practitioners, and students.

Regulatory Impact on Food Product Development in the European Union

  • 1st Edition
  • October 1, 2029
  • Stephen Spice
  • English
Regulatory Aspects of Product Development in the European Union examines the effects of legislation and voluntary agreements when formulating products. With detailed coverage of the entire product development cycle, from concept thorough to the market-place, this book provides a definitive guide to developing products within a regulatory framework. The book is split into four main sections. The first section looks at the background to the agreements which make up the framework with coverage of novel food ingredients, additives and their alternatives, and the development of EU nutrition policy. The second section describes developing a product for various markets which require consideration of regulatory agreements – clean labels, gluten-free, specific health claims, are covered as well as others. Post launch considerations, such as consumer-acceptance, and advertising and marketing of the products are covered in the third section. The final part of the book looks beyond the European Union with chapters covering the regulatory frameworks of the US and beyond, and how this affects product development in these markets. This book is a valuable resource for commercial product developers, food scientists and technologists, technical managers within the food industry, as well as for policy makers and regulators for the food industry.

Infectious Diseases and Public Health

  • 2nd Edition
  • October 1, 2029
  • Davidson H. Hamer + 4 more
  • English
Infectious Diseases and Public Health examines the substantial gains made in public health interventions, the rise in recent decades of a worldwide human immunodeficiency virus (HIV) pandemic, increasing antimicrobial resistance, the emergence of many new bacterial, fungal, parasitic, and viral pathogens, and the economic, social, and political burden of infectious diseases. Given the constantly evolving field of infectious diseases and their continued impact on the health of populations, especially in resource-limited areas of the world, this updated book is very much needed. Students in public health, biomedical professionals, clinicians, public health practitioners, and decisions makers all will find this information relevant to the control and prevention of neglected and emerging diseases worldwide.

Sources, Mechanisms and Toxicity of Nanomaterials in Plants

  • 1st Edition
  • October 1, 2029
  • Jose Peralta-Videa + 2 more
  • English
Plants encounter a wide range of environmental challenges during their life cycle, among which nanoparticle toxicity is a common form of abiotic stress. Nanoparticles can adversely affect various stages of the plant life cycle, such as seed germination, root and shoot growth, chloroplasts ultrastructure and photosynthesis, nutrients assimilation, carbohydrates metabolism, and plant hormonal status, which collectively result in reduced plant yields.Sources, Mechanisms and Toxicity of Nanomaterials in Plants discusses the plant physiology and chemistry involved when plants encounter nanoparticles. Key topics include effects of nanoparticles on photosynthetic responses, regulation of nanoparticle toxicity by nitric oxide, and regulation of nanoparticle toxicity by exogenous application of primary and secondary metabolites.This is the first volume in the new Nanomaterials-Plant Interactions series and is an essential read to all researchers and scientists interested in plant physiology and chemistry, agronomy, nanotechnology and environmental science.

Food Safety Short Stories

  • 1st Edition
  • October 1, 2029
  • Peter Overbosch + 2 more
  • English
Food Safety Short Stories: A Collection of Real-Life Experiences is a novel and unique collection of situations experienced or witnessed by food professionals in the form of short stories. These stories, which focus on an important event, mishap, management practice, or ethical question, present important lessons. Their objective is to educate, inspire, motivate, challenge, and encourage food professionals to better understand food safety management and to help increase job effectiveness and productivity with ethics and integrity. Each story addresses its subject in terms of relevance and application to food safety and covers all types of risks (e.g., microbial, chemical, physical) associated with each step of the food chain. In an entertaining format, the book provides an analysis of incidents or near misses. It highlights pitfalls in food safety management and provides key insight into the means of avoiding them. This book is an essential reference for students and food professionals of all sectors, including scientists, managers, trainers, food inspectors, and those working in the food industry, public health, food control agencies, and certification bodies.

Extracellular Vesicle-Based Therapeutics

  • 1st Edition
  • October 1, 2029
  • Tushar Patel
  • English
Extracellular Vesicles-Based Therapeutics presents the exciting prospect of targeted delivery of drugs through exosomes. Taking a critical perspective, the Editor gathered worldwide experts both in academia and corporate settings to cover all aspects of the subject, from fundamental biological aspects to scaling up production, and regulation. The book is structured in six sections, each covering a distinct topic. Within each section, the authors and chapters were selected to provide a balanced coverage. Section I deals with the fundamentals of EV biology: types, formation, interactions and effects. Section II covers Extracellular Vesicles (EVs) isolation, and purification approaches. Section III presents EV production platforms, providing a framework and guidelines by which clinically usable and consistent EV therapeutics could be manufactured. Section IV covers preclinical studies and applications, reviewing studies that provide opportunities to identify disease-relevant indications for EV therapeutics and to guide their translation to clinical trials. Section V presents drug development and commercialization of EV therapeutics, covering considerations in regulatory approvals and market access for EV based therapeutics. Section VI covers clinical trials of EV therapeutics, outlining a framework for clinical evaluation, including study design and clinical trials strategies and examples of on-going trials of EV-based therapeutics. Extracellular Vesicles-Based Therapeutics is a complete resource for researchers in this exciting area. Its breadth of coverage makes it particularly interesting to pharmaceutical researchers exploring the potential of this platform for targeted drug delivery. Physicians, Regulators, Laboratory directors and Industry executives in biotechnology would also benefit from the contents in this book.